Literature DB >> 24172151

Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Everardo Vega1, Leslie Barclay, Nicole Gregoricus, S Hannah Shirley, David Lee, Jan Vinjé.   

Abstract

Noroviruses are the leading cause of epidemic acute gastroenteritis in the United States. From September 2009 through August 2013, 3,960 norovirus outbreaks were reported to CaliciNet. Of the 2,895 outbreaks with a known transmission route, person-to-person and food-borne transmissions were reported for 2,425 (83.7%) and 465 (16.1%) of the outbreaks, respectively. A total of 2,475 outbreaks (62.5%) occurred in long-term care facilities (LTCF), 389 (9.8%) in restaurants, and 227 (5.7%) in schools. A total of 435 outbreaks (11%) were typed as genogroup I (GI) and 3,525 (89%) as GII noroviruses. GII.4 viruses caused 2,853 (72%) of all outbreaks, of which 94% typed as either GII.4 New Orleans or GII.4 Sydney. In addition, three non-GII.4 viruses, i.e., GII.12, GII.1, and GI.6, caused 528 (13%) of all outbreaks. Several non-GII.4 genotypes (GI.3, GI.6, GI.7, GII.3, GII.6, and GII.12) were significantly more associated with food-borne transmission (odds ratio, 1.9 to 7.1; P < 0.05). Patients in LTCF and people ≥65 years of age were at higher risk for GII.4 infections than those in other settings and with other genotypes (P < 0.05). Phylogeographic analysis identified three major dispersions from two geographic locations that were responsible for the GI.6 outbreaks from 2011 to 2013. In conclusion, our data demonstrate the cyclic emergence of new (non-GII.4) norovirus strains, and several genotypes are more often associated with food-borne outbreaks. These surveillance data can be used to improve viral food-borne surveillance and to help guide studies to develop and evaluate targeted prevention methods such as norovirus vaccines, antivirals, and environmental decontamination methods.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24172151      PMCID: PMC3911414          DOI: 10.1128/JCM.02680-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

2.  Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006.

Authors:  Du-Ping Zheng; Marc-Alain Widdowson; Roger I Glass; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

3.  Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States.

Authors:  Catherine Yen; Mary E Wikswo; Ben A Lopman; Jan Vinje; Umesh D Parashar; Aron J Hall
Journal:  Clin Infect Dis       Date:  2011-08-10       Impact factor: 9.079

4.  Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007.

Authors:  Ben A Lopman; Aron J Hall; Aaron T Curns; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2011-01-22       Impact factor: 9.079

5.  A large multi-pathogen waterborne community outbreak linked to faecal contamination of a groundwater system, France, 2000.

Authors:  A Gallay; H De Valk; M Cournot; B Ladeuil; C Hemery; C Castor; F Bon; F Mégraud; P Le Cann; J C Desenclos
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

6.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

7.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

8.  Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.

Authors:  Lisa C Lindesmith; Martina Beltramello; Eric F Donaldson; Davide Corti; Jesica Swanstrom; Kari Debbink; Antonio Lanzavecchia; Ralph S Baric
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

9.  Use of norovirus genotype profiles to differentiate origins of foodborne outbreaks.

Authors:  Linda Verhoef; Harry Vennema; Wilfrid van Pelt; David Lees; Hendriek Boshuizen; Kathleen Henshilwood; Marion Koopmans
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

10.  Emergence of new norovirus strain GII.4 Sydney--United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-25       Impact factor: 17.586

View more
  142 in total

1.  Comparative genome analysis of a norovirus GII.4 strain GZ2013-L10 isolated from South China.

Authors:  Liang Xue; Weicheng Cai; Qingping Wu; Xiaoxia Kou; Jumei Zhang; Weipeng Guo
Journal:  Virus Genes       Date:  2016-01-04       Impact factor: 2.332

2.  Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.

Authors:  Maria Malm; Kirsi Tamminen; Suvi Lappalainen; Hanni Uusi-Kerttula; Timo Vesikari; Vesna Blazevic
Journal:  Clin Vaccine Immunol       Date:  2015-04-22

Review 3.  Norovirus Illnesses in Children and Adolescents.

Authors:  Minesh P Shah; Aron J Hall
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

Review 4.  Emergence of norovirus strains: A tale of two genes.

Authors:  Gabriel I Parra
Journal:  Virus Evol       Date:  2019-11-25

Review 5.  Advances in laboratory methods for detection and typing of norovirus.

Authors:  Jan Vinjé
Journal:  J Clin Microbiol       Date:  2014-07-02       Impact factor: 5.948

6.  Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant Viruses.

Authors:  Jennifer L Cannon; Leslie Barclay; Nikail R Collins; Mary E Wikswo; Christina J Castro; Laura Cristal Magaña; Nicole Gregoricus; Rachel L Marine; Preeti Chhabra; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

7.  The state of norovirus vaccines.

Authors:  Kari Debbink; Lisa C Lindesmith; Ralph S Baric
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

Review 8.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

Review 9.  Viruses in Rodent Colonies: Lessons Learned from Murine Noroviruses.

Authors:  Stephanie M Karst; Christiane E Wobus
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

10.  Emergence of a novel GII.17 norovirus – End of the GII.4 era?

Authors:  M de Graaf; J van Beek; H Vennema; A T Podkolzin; J Hewitt; F Bucardo; K Templeton; J Mans; J Nordgren; G Reuter; M Lynch; L D Rasmussen; N Iritani; M C Chan; V Martella; K Ambert-Balay; J Vinjé; P A White; M P Koopmans
Journal:  Euro Surveill       Date:  2015-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.